Bonus BioGroup Balance Sheet Health
Financial Health criteria checks 4/6
Bonus BioGroup has a total shareholder equity of ₪15.4M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪32.0M and ₪16.6M respectively.
Key information
0%
Debt to equity ratio
₪0
Debt
| Interest coverage ratio | n/a |
| Cash | ₪14.14m |
| Equity | ₪15.40m |
| Total liabilities | ₪16.62m |
| Total assets | ₪32.02m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BBIX.F's short term assets (₪14.6M) exceed its short term liabilities (₪7.5M).
Long Term Liabilities: BBIX.F's short term assets (₪14.6M) exceed its long term liabilities (₪9.1M).
Debt to Equity History and Analysis
Debt Level: BBIX.F is debt free.
Reducing Debt: BBIX.F had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BBIX.F has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BBIX.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.4% each year